Comment
doi: 10.1093/eurheartj/ehz223.
Aspirin for primary cardiovascular prevention: is there a need for risk stratification?
Affiliations
- PMID: 31005987
- DOI: 10.1093/eurheartj/ehz223
Item in Clipboard
Comment
Aspirin for primary cardiovascular prevention: is there a need for risk stratification?
Eur Heart J.
.
No abstract available
Comment in
-
Response to Commentary for 'Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials'.Eur Heart J. 2019 Sep 7;40(34):2924-2925. doi: 10.1093/eurheartj/ehz224. Eur Heart J. 2019. PMID: 31005974 No abstract available.
Comment on
-
Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials.Eur Heart J. 2019 Feb 14;40(7):607-617. doi: 10.1093/eurheartj/ehy813. Eur Heart J. 2019. PMID: 30561620
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
